{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:52:50Z","timestamp":1785412370310,"version":"3.56.0"},"reference-count":54,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fundamental Fund 2025","award":["207555"],"award-info":[{"award-number":["207555"]}]},{"DOI":"10.13039\/501100002842","name":"Chiang Mai University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002842","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/05m2fqn25","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","award":["FRB690042\/0162"],"award-info":[{"award-number":["FRB690042\/0162"]}],"id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]},{"award":["FRB690042\/0162"],"award-info":[{"award-number":["FRB690042\/0162"]}],"id":[{"id":"https:\/\/ror.org\/000025p04","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background\/Objectives: Tuberculosis (TB), caused by Mycobacterium tuberculosis complex, remains a major global health challenge. Recently, D-enantiomer of human lactoferricin 1\u201311 (D-form hLF 1\u201311), a short peptide derived from the N-terminal region of lactoferrin, has demonstrated potent antimycobacterial activity. However, its direct mechanism of action has not yet been elucidated. Methods &amp; Results: In the present study, M. smegmatis was employed as a model organism to investigate the mechanism underlying D-form hLF 1\u201311 activity. Initially, the minimum inhibitory concentration (MIC) was determined and the results revealed growth inhibition at 400 \u00b5g\/mL. Live\/dead fluorescence staining demonstrated mycobactericidal activity, as indicated by increased propidium iodide (PI) uptake relative to the untreated control. Scanning electron microscopy and high-resolution fluorescence microscopy revealed membrane disruption and substantial morphological deformation, along with a time-dependent accumulation of the peptide at the membrane and inside the cells. Furthermore, label-free quantitative proteomic analysis of peptide-treated cells revealed extensive metabolic alterations in carbon metabolism, acetyl-CoA-dependent lipid biosynthesis, oxidative stress defense, translational machinery, and energy production systems. Conclusions: Collectively, these findings provide mechanistic insights into the antimycobacterial activity of D-form hLF 1\u201311 against M. smegmatis.<\/jats:p>","DOI":"10.3390\/antibiotics15060607","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:46:28Z","timestamp":1781588788000},"page":"607","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elucidation of the Antimycobacterial Activity of D-Form Human Lactoferricin 1\u201311 (D-Form hLF 1\u201311) Against Mycobacterium smegmatis Through Proteomics and Imaging Analysis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-4750","authenticated-orcid":false,"given":"Sorasak","family":"Intorasoot","sequence":"first","affiliation":[{"name":"Division of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"},{"name":"Infectious Diseases Research Unit, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whichayanan","family":"Doung-Arpai","sequence":"additional","affiliation":[{"name":"Division of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amornrat","family":"Intorasoot","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8812-5139","authenticated-orcid":false,"given":"Khajornsak","family":"Tragoolpua","sequence":"additional","affiliation":[{"name":"Division of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"},{"name":"Infectious Diseases Research Unit, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4987-5505","authenticated-orcid":false,"given":"Sirikwan","family":"Sangboonruang","sequence":"additional","affiliation":[{"name":"Division of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"},{"name":"Infectious Diseases Research Unit, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8560-6540","authenticated-orcid":false,"given":"Bordin","family":"Butr-Indr","sequence":"additional","affiliation":[{"name":"Division of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"},{"name":"Infectious Diseases Research Unit, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6648-8972","authenticated-orcid":false,"given":"Usanee","family":"Wattananandkul","sequence":"additional","affiliation":[{"name":"Division of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"},{"name":"Infectious Diseases Research Unit, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ponrut","family":"Phunpae","sequence":"additional","affiliation":[{"name":"Division of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"},{"name":"Infectious Diseases Research Unit, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1441-9641","authenticated-orcid":false,"given":"Chayada Sitthidet","family":"Tharinjaroen","sequence":"additional","affiliation":[{"name":"Division of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"},{"name":"Infectious Diseases Research Unit, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41579-025-01159-w","article-title":"Ecology, global diversity and evolutionary mechanisms in the Mycobacterium tuberculosis complex","volume":"23","author":"Goig","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Yang, H., Ruan, X., Li, W., and Zhang, Y. (2024). Global, regional, and national burden of tuberculosis and attributable risk factors for 204 countries and territories, 1990\u20132021: A systematic analysis for the global burden of diseases 2021 study. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-20664-w"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41572-024-00504-2","article-title":"Multidrug-resistant tuberculosis","volume":"10","author":"Dheda","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","unstructured":"World Health Organization (2025). Global Tuberculosis Report 2025, World Health Organization. Available online: http:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2025."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/CLEP.S35839","article-title":"Extensively drug-resistant tuberculosis: Epidemiology and management","volume":"6","author":"Matteelli","year":"2014","journal-title":"Clin. Epidermiol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lu, J., Xu, H., Xia, J., Ma, J., Xu, J., Li, Y., and Feng, J. (2020). D-and unnatural amino acid substituted antimicrobial peptides with improved proteolytic resistance and their proteolytic degradation characteristics. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.563030"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13568-016-0295-8","article-title":"Antimicrobial activity and stability of the D-amino acid substituted derivatives of antimicrobial peptide polybia-MPI","volume":"6","author":"Zhao","year":"2016","journal-title":"AMB Expr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijantimicag.2012.09.015","article-title":"Activity of LL-37, CRAMP and antimicrobial peptide-derive compounds E2, E6 and CP26 against Mycobacterium tuberculosis","volume":"41","author":"Hancock","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_9","first-page":"7515687","article-title":"Defensins: The case for their use against mycobacterium infections","volume":"20","author":"Dong","year":"2016","journal-title":"J. Immunol. Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ostrowka, M., Duda-Madej, A., Pietluch, F., Mackiewicz, P., and Gagat, P. (2023). Testing antimicrobial properties of human lactoferrin-derived fragments. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310529"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1086\/522427","article-title":"Human lactoferrin-derived peptide\u2019s antifungal activities against disseminated Candida albicans infection","volume":"196","author":"Lupetti","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Intorasoot, S., Intorasoot, A., Tawteamwong, A., Butr-Indr, B., Phunpae, P., Tharinjaroen, C.S., Wattananandkul, U., Sangboonruang, S., and Khantipongse, J. (2022). In vitro antimycobacterial activity of human lactoferrin-derived peptide, D-hLF 1-11, against susceptible and drug-resistant Mycobacterium tuberculosis and its synergistic effect with rifampicin. Antibiotics, 11.","DOI":"10.3390\/antibiotics11121785"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"19029","DOI":"10.1038\/s41598-025-04673-2","article-title":"Exploring intracellular antimycobacterium activity of lactoferricin-loaded niosomes: Proteomics insights into immunomodulation","volume":"15","author":"Sangboonruang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e0033722","DOI":"10.1128\/jb.00337-22","article-title":"Mycobacterium smegmatis: The vanguard of mycobacterial research","volume":"205","author":"Sparks","year":"2023","journal-title":"J. Bacteriol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: Augmenting protein-chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.peptides.2014.07.006","article-title":"A study of effects of peptide fragments of bovine and human lactoferrins on activities of three key HIV-1 enzymes","volume":"62","author":"Wong","year":"2014","journal-title":"Peptides"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sanchez-Gomez, S., Ferrer-Espada, R., Stewart, P.S., Pitts, B., Lohner, K., and de Tejada, G.M. (2015). Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms. BMC Microbiol., 15.","DOI":"10.1186\/s12866-015-0473-x"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Brouwer, C., van der Linden, Y., Carrasco, M.R., Alwasel, S., Abalkhail, T., Al-Otibi, F.O., Boekhout, T., and Welling, M.M. (2025). Synthetic human lactoferrin peptide hLF (1-11) shows antifungal activity and synergism with fluconazole and anidulafungin towards Candica albicans and various non-albicans Candida species, including Candidozyma auris. Antibiotics, 14.","DOI":"10.3390\/antibiotics14070671"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4049\/jimmunol.1900801","article-title":"Requirement of the complement c6 for innate immune responses in mice","volume":"205","author":"Fattahi","year":"2020","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41420-023-01731-4","article-title":"TRAF6 triggers Mycobacterium-infected host autophagy through Rab7 ubiquitination","volume":"9","author":"Ma","year":"2023","journal-title":"Cell. Death Discov."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.bi.64.070195.000333","article-title":"The envelope of mycobacteria","volume":"64","author":"Brennan","year":"1995","journal-title":"Annu. Rev. Biochem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1574-6968.1994.tb07194.x","article-title":"Mycobacterial cell wall: Structure and role in natural resistance to antibiotics","volume":"123","author":"Jarlier","year":"1994","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1128\/AAC.02728-13","article-title":"Killing of Mycobacterium avium by lactoferricin peptides: Improve activity of arginine- and D-amino-acid-containing molecules","volume":"58","author":"Silva","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Benfield, A.H., and Henriques, S.T. (2020). Mode-of-action of antimicrobial peptides: Membrane disruption vs. intracellular mechanisms. Front. Med. Technol., 2.","DOI":"10.3389\/fmedt.2020.610997"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Bruni, N., Capucchio, M.T., Biasibetti, E., Pessione, E., Cirrincione, S., Giraudo, L., Corona, A., and Dosio, F. (2016). Antimicrobial activity of lactoferrin-related peptides and applications in human and veterinary medicine. Molecules, 21.","DOI":"10.3390\/molecules21060752"},{"key":"ref_26","first-page":"1","article-title":"Lactoferrin-lipopolysaccharide (LPS) binding as key to antibacterial and antiendotoxic effects","volume":"12","author":"Luna","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.archoralbio.2011.02.004","article-title":"Antimicrobial and DNA-binding activities of the peptide fragments of human lactoferrin and histatin 5 against Streptococcus mutans","volume":"56","author":"Huo","year":"2011","journal-title":"Ach. Oral Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e02767-22","DOI":"10.1128\/spectrum.02767-22","article-title":"Sensitization of KPC and NDM Klebsiella pneumoniae to rifampicin by the human lactoferricin-derived peptide hLF 1-11","volume":"11","author":"Morici","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_29","first-page":"48","article-title":"Antimicrobial peptides: Mechanism of action, activity and clinical potential","volume":"8","author":"Zhang","year":"2021","journal-title":"Mil. Med. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1021\/acs.jproteome.6b00403","article-title":"A proteomics approach to the protein normalization problem: Selection of unvarying proteins for MS-based proteomics and Western blotting","volume":"15","author":"Wisniewski","year":"2016","journal-title":"J. Proteome Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1021\/acs.jproteome.6b00312","article-title":"Advanced precursor ion selection algorithms for increased depth of bottom-up proteomic profiling","volume":"15","author":"Kreimer","year":"2016","journal-title":"J. Proteome Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"107052","DOI":"10.1016\/j.mimet.2024.107052","article-title":"Evaluation of protein extraction protocols for MALDI-TOF biotyper analysis of mycobacteria","volume":"227","author":"Machnik","year":"2024","journal-title":"J. Microbiol. Methods"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbagen.2011.05.010","article-title":"On the functional diversity of glyceraldehyde-3-phosphate dehydrogenase: Biochemical mechanisms and regulatory control","volume":"1810","author":"Sirover","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/CMR.18.1.81-101.2005","article-title":"Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis","volume":"18","author":"Takayama","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2012.11.010","article-title":"Aldehyde dehydrogenases in cellular responses to oxidative\/electrophile stress","volume":"56","author":"Singh","year":"2012","journal-title":"Free Redic. Biol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1099\/00221287-148-10-3139","article-title":"Oxidative stress response genes in mycobacteria: Role of catalase-peroxidase KatG and related enzymes","volume":"148","author":"Master","year":"2002","journal-title":"Microbiology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1021\/acs.biochem.4c00763","article-title":"Glutamine synthetase: Diverse regulation and function of an ancient enzyme","volume":"64","author":"Tecson","year":"2025","journal-title":"Biochemistry"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1128\/jb.169.2.699-703.1987","article-title":"Dienelactone hydrolase from Pseudomonas sp. strain B13","volume":"169","author":"Ngai","year":"1987","journal-title":"J. Bacteriol."},{"key":"ref_39","first-page":"3644","article-title":"An ANTAR RNA-binding protein regulates mycobacterial metabolic adaptation through a phosphorylation-dependent signaling pathway","volume":"46","author":"Narayanan","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_40","first-page":"466","article-title":"The sensor kinase PdtaS is essential for nutrient deprivation adaptation and controls lipid metabolism in mycobacteria","volume":"4","author":"Hariharan","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1126\/science.1192588","article-title":"Interdependence of cell growth and gene expression: Origins and consequences","volume":"330","author":"Scott","year":"2010","journal-title":"Science"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"126608","DOI":"10.1016\/j.micres.2020.126608","article-title":"Exploring antimicrobial mechanism of essential oil of Amomum villosum Lour through metabolomics based on gas chromatography-mass spectrometry in methicillin-resistant Staphylococcus aureus","volume":"242","author":"Tang","year":"2021","journal-title":"Microbiol. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.celrep.2017.04.002","article-title":"Nontargeted metabolomics reveals the multilevel response to antibiotic perturbation","volume":"19","author":"Zampieri","year":"2017","journal-title":"Cell Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/pmic.201400279","article-title":"Proteomic alteration of equine monocyte-derived macrophages infected with equine infectious anemia virus","volume":"15","author":"Du","year":"2015","journal-title":"Proteomics"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1021\/pr0703066","article-title":"The proteomic response of Mycobacterium smegmatis to anti-tuberculosis drugs suggests targeted pathways","volume":"7","author":"Wang","year":"2008","journal-title":"J. Proteome Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1074\/jbc.RA118.006968","article-title":"A small mycobacteriophage-derive peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities","volume":"294","author":"Yang","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_47","unstructured":"Clinical and Laboratory Standards Institute (2011). Susceptibility Testing of Mycobacteria, Nocardia, and Other Aerobic Actinomycetes: Approved Standard-Second Edition. M24-A2, Clinical and Laboratory Standards Institute."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2144\/btn-2020-0036","article-title":"Optimization of staining with SYTO 9\/propidium iodide: Interplay, kinetics and impact on Brevibacillus brevis","volume":"69","author":"Deng","year":"2020","journal-title":"BioTechniques"},{"key":"ref_49","first-page":"100916","article-title":"A simple method for quantitating confocal fluorescent images","volume":"25","author":"Shihan","year":"2021","journal-title":"Biochem. Biophy. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.4014\/jmb.1901.01021","article-title":"Proteomic and morphologic evidence for taurine-5-bromosalicylaldehyde schiff base as an efficient anti-mycobacterial drug","volume":"29","author":"Ding","year":"2019","journal-title":"J. Microbial. Biotechol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1021\/acs.biomac.7b00210","article-title":"Evaluation of the antimicrobial activity of cationic polymers against Mycobacteria: Toward antitubercular macromolecules","volume":"18","author":"Phillips","year":"2017","journal-title":"Biomacromolecules"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.4155\/fmc-2019-0095","article-title":"Using fluorescence microscopy to shed light on the mechanisms of antimicrobial peptides","volume":"11","author":"Buck","year":"2019","journal-title":"Future Med. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.1002\/pld3.528","article-title":"Hormonal and proteomic analyses of southern blight disease caused by Athelia rolfsii and root chitosan priming on Cannabis sativa in an in vitro hydroponic system","volume":"7","author":"Suwanchaikasem","year":"2023","journal-title":"Plant Direct."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1038\/s41598-024-59860-4","article-title":"Quality control in SARS-CoV-2 RBD-Fc vaccine production using LC-MS to confirm strain selection and detect contaminations from other strains","volume":"14","author":"Suwanchaikasem","year":"2024","journal-title":"Sci. Rep."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/6\/607\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:13:27Z","timestamp":1781842407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/6\/607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["antibiotics15060607"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15060607","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}